Stock detail

Elevance Health (ELV) stock price, chart, and key data

View Elevance Health stock price, chart movement, and headline metrics on Woodstock's stock detail page.

ELV

Stock detail

Elevance Health

ELV · XNYS

+$6.18 (+1.59%) past day

$395.18

Overnight $392.58 (-0.66%)

XNYS24/5 tradingLast updated: Jul 25, 01:01 PM

Key metrics

Financials

Quarterly revenue, profitability, and balance-sheet snapshot

50.7B40.6B30.4B20.3B10.1B0
2025 Q2Q3Q42026 Q1
RevenueNet income

Dividend

Past Dividend Performance

$1.72

$1.72

$1.72

2026/32026/62026/9

Annual Dividend Yield

1.74%

Dividend

$1.72 / Stock

Frequency

Quarterly Payment

Day range

$376.15 - $394.26

Close price

$379.31

Market cap

$82.3B

P/E ratio

49.4

About the company

Elevance Health, Inc.

Elevance Health, Inc. is an American health insurance company. Prior to June 2022, Elevance Health was named Anthem, Inc. The company is the world's seventh largest healthcare company based on revenue. Its services include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans through affiliated companies such as Anthem Blue Cross and Blue Shield, Anthem Blue Cross in California, Wellpoint, and Carelon. It is the largest for-profit managed health care company in the Blue Cross Blue Shield Association. As of 2022, the company had 46.8 million members within its affiliated companies' health plans. Based on its 2021 revenues, the company ranked 20th on the 2022 Fortune 500. In 2023, the company's seat in Forbes Global 2000 rankings was 78. Carelon Global Solutions, Elevance Health's Business Process Outsourcing /Shared Services subsidiary, serves the group's offshore and customer service management. It operates sites in India, Puerto Rico, Philippines, and the United States.

Analyst rating summary

A current read on analyst sentiment from the insight feed.

Mean target

$449

Current price $378
Low$393High$498

13

Buy

/ 19

Recent calls

07/21/2026

Bernstein

Lance Wilkes

Buy · Price target $488

07/20/2026

Barclays

Andrew Mok CFA

Buy · Price target $457

07/17/2026

Leerink Partners

Whit Mayo

Hold · Price target $395

Ticker holders

Review politician disclosures and insider transactions in tabs.

Holder directory

Select a heading to reorder by name, activity date, buy/sell, or displayed value.

14/14

#1Markwayne Mullin

republican · Executive · OK

joint
  • Buy$15,001 / $32,501 / $50,000
$15,001/$32,501/$50,000

#2Michael McCaul

republican · House · TX-10

spouse
  • Sell$15,001 / $32,501 / $50,000
$15,001/$32,501/$50,000

#3Ro Khanna

democrat · House · CA-17

child
  • Sell$1,000 / $8,000 / $15,000
  • Buy$1,001 / $8,001 / $15,000
  • Sell$1,000 / $8,000 / $15,000
$3,001/$24,001/$45,000

#4Alan Armstrong

self
  • Buy$1,001 / $8,001 / $15,000
$1,001/$8,001/$15,000

#5Sheldon Whitehouse

democrat · Senate · RI

self
2024
203/135/271

#6Robert Wittman

republican · House · VA-1

self
2024
88/40/135

#7Ro Khanna

democrat · House · CA-17

spouse
  • Buy$1,001 / $8,001 / $15,000
50/6/94

#8Gilbert Cisneros

democrat · House · CA-31

self
  • Buy$1,001 / $8,001 / $15,000
28/3/54

#9Rob Bresnahan

republican · House · PA-8

self
2024
21/2/40

#10Donald J Trump

republican · Executive

self
2026
19/2/36

#11Lisa McClain

republican · House · MI-9

spouse
  • Sell$1,001 / $8,001 / $15,000
  • Buy$1,001 / $8,001 / $15,000
17/2/32

#12Jefferson Shreve

republican · House · IN-6

self
2024
6/2/9

#13Dan Newhouse

republican · House · WA-4

spouse
2024
3/0/6

#14Valerie Hoyle

democrat · House · OR-4

spouse
2024
1/0/2

Market action

A concise summary of the latest filing, transaction, or market-moving item.

Elevance Health, Inc. insider Ramiro G. Peru reported a Form 4 ownership change involving the company’s common stock on July 17, 2026. The filing lists a transaction in 1,000 shares at a price of $366.05 per share, representing an implied transaction value of approximately $366,050. The document identifies the security as Elevance Health common stock and ties the reported ownership change to the same date as the filing and report date, July 17, 2026. The filing was signed on Peru’s behalf by Kathleen S. Kiefer as attorney-in-fact. The excerpt provided does not specify the transaction code, so it does not clearly indicate whether the 1,000-share transaction was an open-market purchase, sale, grant-related disposition, or another type of reportable insider transaction. It also does not show the number of shares beneficially owned after the transaction, whether the holdings were direct or indirect, or any derivative-security details such as options, restricted stock units, vesting schedules, or exercise prices. Even with those limitations, the filing is notable because Form 4 reports are used to disclose changes in ownership by company insiders, giving investors visibility into transactions by directors, officers, or other reporting persons in the company’s equity securities.

24/5 Trading

Act on the stock when the timing works for you.

With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.

*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.

Download the app
24/5 trading chart preview

Sign Up

Scan the QR code to get started

Contact via LINE

Scan the QR code to get started

LINE QR Code